Brief: Lansen Pharm Posts HY Profit Attributable US$96.4 MLN
Aug 27 (Reuters) - Lansen Pharmaceutical Holdings Ltd
0503.HK :
* HY PROFIT ATTRIBUTABLE US$96.4 MILLION VERSUS US$4.8
MILLION
* HY REVENUE US$26.8 MILLION VERSUS US$26.2 MILLION
Source text for Eikon: ID:nHKS1N0JcQ
Further company coverage: 0503.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lansen Pharmaceutical Holdings
See all newsBrief: Lansen Pharmaceutical Says Stock Exchange Approved Withdrawal Of Listing Of Shares From 9 AM, 19 Dec
Brief: Lansen Pharmaceutical Updates Withdrawal Of Listing Of Shares On Stock Exchange
Brief: Lansen Pharmaceutical Says Trading In Shares Will Be Halted
Brief: Lansen Pharmaceutical Posts FY Revenue Of $65.6 Mln VS $54.2 Mln
Brief: Lansen Pharmaceutical Sees Net Profit Attributable Of Approximately $8.1 Million For Year